|
|
Human Subject Research Ethics: Issues for Going from
Bench to Bedside
Sponsored by
APS Public Affairs Committee
Education
Track
Saturday, April 28 — 3:15-5:15 PM
Washington, DC Convention Center — Room 147B
|
| Chaired: |
Michael Portman, Children’s Hosp, Seattle
Virginia Miller, Mayo Clin. Col. of Med. |
Translational research broadly describes scientific
research that drives the transfer of knowledge from basic bench science to
clinical trials and the development of clinically useful treatments and
interventions. Funding agencies such as the National Institutes of Health
have recently placed an increased emphasis on translational research, hoping
to speed the transition from bench to bedside. However, the pursuit of
translational research brings a new and diverse set of ethical challenges to
basic scientists including the appropriate design of research involving
human subjects, obtaining informed consent and protecting the privacy of
research participants, dealing with intellectual property and licensing
issues while minimizing conflicts of interest, and navigating a complex
regulatory environment. This symposium will define the major ethical
challenges facing scientists engaged in translational research, offer
suggestions for successfully dealing with those challenges and ideas for
future policy changes that may ease the difficulties in navigating a complex
regulatory environment.
|
3:15 PM |
An ethical roadmap to translational research.
Lainie Friedman Ross, Univ. of Chicago
|
|
3:45 PM |
TBA
Ken Massey, Pifzer Global Res. and Dev.
|
|
4:15 PM |
TBA
Thomas F. Bumol, Eli Lilly and Co.
|
|
4:45 PM |
Creating a marketable product through translational research.
David L. Wynes, Univ. of Iowa
|
|
|